UnitedHealth Group Incorporated (NYSE:UNH) Position Decreased by Princeton Global Asset Management LLC

Princeton Global Asset Management LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 18,093 shares of the healthcare conglomerate’s stock after selling 82 shares during the period. UnitedHealth Group makes up 2.2% of Princeton Global Asset Management LLC’s investment portfolio, making the stock its 6th largest position. Princeton Global Asset Management LLC’s holdings in UnitedHealth Group were worth $6,345,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in UNH. Alliancebernstein L.P. increased its stake in UnitedHealth Group by 5.2% in the fourth quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after purchasing an additional 569,142 shares during the last quarter. Findlay Park Partners LLP increased its position in UnitedHealth Group by 69.0% during the 3rd quarter. Findlay Park Partners LLP now owns 1,225,000 shares of the healthcare conglomerate’s stock worth $381,918,000 after purchasing an additional 500,000 shares in the last quarter. First Trust Advisors LP boosted its stake in UnitedHealth Group by 402.0% in the 4th quarter. First Trust Advisors LP now owns 521,127 shares of the healthcare conglomerate’s stock worth $182,749,000 after buying an additional 417,327 shares during the last quarter. Morgan Stanley lifted its position in UnitedHealth Group by 4.9% during the 3rd quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock worth $2,183,416,000 after acquiring an additional 325,936 shares in the last quarter. Finally, CIBC Private Wealth Group LLC increased its holdings in UnitedHealth Group by 25.5% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 1,579,134 shares of the healthcare conglomerate’s stock worth $492,232,000 after purchasing an additional 321,008 shares during the last quarter. Institutional investors own 86.03% of the company’s stock.

In other news, EVP Marianne D. Short sold 9,681 shares of the business’s stock in a transaction on Tuesday, December 29th. The stock was sold at an average price of $348.00, for a total transaction of $3,368,988.00. Following the sale, the executive vice president now directly owns 167,202 shares of the company’s stock, valued at $58,186,296. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Marianne D. Short sold 9,993 shares of the company’s stock in a transaction dated Tuesday, January 5th. The stock was sold at an average price of $348.69, for a total value of $3,484,459.17. Insiders sold a total of 37,293 shares of company stock valued at $12,886,401 over the last quarter. Company insiders own 0.80% of the company’s stock.

A number of equities research analysts have recently issued reports on the company. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $360.00 to $375.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 2nd. SVB Leerink upped their price target on UnitedHealth Group from $378.00 to $390.00 and gave the stock an “outperform” rating in a research note on Monday, December 14th. Truist increased their target price on UnitedHealth Group from $400.00 to $420.00 in a research note on Tuesday, January 5th. Raymond James increased their target price on UnitedHealth Group from $355.00 to $405.00 and gave the company a “strong-buy” rating in a research note on Wednesday, December 2nd. Finally, Barclays reiterated a “buy” rating and issued a $405.00 price objective on shares of UnitedHealth Group in a research report on Sunday, January 17th. Five investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $387.82.

Shares of UNH stock traded up $0.66 during mid-day trading on Tuesday, reaching $328.30. The stock had a trading volume of 74,607 shares, compared to its average volume of 3,453,442. UnitedHealth Group Incorporated has a 12-month low of $187.72 and a 12-month high of $367.95. The company has a market cap of $311.50 billion, a P/E ratio of 18.82, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. The business has a 50-day simple moving average of $341.25 and a 200 day simple moving average of $330.10. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.39 by $0.13. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business had revenue of $65.47 billion during the quarter, compared to analysts’ expectations of $64.98 billion. During the same quarter last year, the business posted $3.90 earnings per share. The business’s revenue for the quarter was up 7.5% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Recommended Story: Stock Market – What is a circuit breaker?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.